CLOs on the Move

Medpace

www.medpace.com

 
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion
  • www.medpace.com
  • 5375 Medpace Way
    Cincinnati, OH USA 45227
  • Phone: 513.579.9911

Executives

Name Title Contact Details

Similar Companies

Gentis Inc

Gentis Inc is a Wayne, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Phonic Ear

Phonic Ear is a Petaluma, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Citagenix Inc

Citagenix Inc is a Laval, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)

Bodypoint

Bodypoint is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.